Thrivent Financial for Lutherans’s Genomic Health, Inc. GHDX Stock Holding History

Thrivent Financial for Lutherans’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-17,171	Closed	-$1.17M	–	2291
2019 Q3	$1.17M	Buy	+17,171	New	+$1.18M	﹤0.01%	1306
2019 Q1	–	Sell	-15,029	Closed	-$968K	–	2189
2018 Q4	$968K	Buy	15,029 +7,790	+108%	+$546K	﹤0.01%	1174
2018 Q3	$508K	Hold	7,239	–	–	﹤0.01%	1675
2018 Q2	$365K	Buy	+7,239	New	+$287K	﹤0.01%	1829

Thrivent Financial for Lutherans's GHDX Position: Q4 2019 in Review

Thrivent Financial for Lutherans sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 17,171 shares — an estimated $1.17M sold.

Thrivent Financial for Lutherans first reported a position in GHDX in Q2 2018 and held it in 4 quarters. The position peaked at $1.17M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Thrivent Financial for Lutherans reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Thrivent Financial for Lutherans sold 17,171 Genomic Health, Inc. shares in Q4 2019, an estimated $1.17M.
Thrivent Financial for Lutherans first reported a position in Genomic Health, Inc. in Q2 2018 and held it in 4 quarters.
Thrivent Financial for Lutherans's Genomic Health, Inc. position peaked at $1.17M in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2019, filed 13 Feb 2020.